Ocular Nutrition FTC settlement
This article was originally published in The Tan Sheet
Executive Summary
Hi-Health Supermart Corp. and its owner Simon Chalpin will pay $450,000 to settle FTC charges that the firm made unsubstantiated claims for its dietary supplement, FTC announces Feb. 15. The commission cited advertisements stating Ocular Nutrition "can restore vision already lost from age-related macular degeneration" and can "eliminate small specks moving in the field of vision (called floaters)." The settlement bans the defendants from "making claims about the benefits, performance, efficacy or safety" of any health-related product or dietary supplement "unless they have competent and reliable scientific evidence," FTC says...
You may also be interested in...
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.